Led by $635m acquisition of Capsule Technologies, North America’s medical devices industry saw a rise of 34.83% in cross border deal activity during Q1 2021, when compared to the last four-quarter average, according to GlobalData’s deals database.
A total of 60 cross border deals worth $2.25bn were announced for the region during Q1 2021, against the last four-quarter average of 44.50 deals.
Of all the deal types, venture financing saw most activity in Q1 2021 with 31 deals, representing a 51.7% share for the region.
